Numerous studies have established a correlation between NAFLD and elevated levels of specific biochemical markers, including alanine aminotransferase (ALT), triglycerides, total cholesterol, and indicators of hepatic lipid accumulation and damage [6,7,8,9]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.